Gene · 8205
Papers2,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Macrophage infiltration in 3D cancer spheroids to recapitulate the TME and unveil interactions within cancer cells and macrophages to modulate chemotherapeutic drug efficacy. | BMC Cancer | 2023 | 38062442 | PubTator, text mining | PubMed |
| BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition. | Mil Med Res | 2023 | 38049916 | PubTator, text mining | PubMed |
| Structure-based drug discovery of novel fused-pyrazolone carboxamide derivatives as potent and selective AXL inhibitors. | Acta Pharm Sin B | 2023 | 38045061 | PubTator, text mining | PubMed |
| Targeting the epigenome to reinvigorate T cells for cancer immunotherapy. | Mil Med Res | 2023 | 38044445 | PubTator, text mining | PubMed |
| Cancer stem cells and their niche in cancer progression and therapy. | Cancer Cell Int | 2023 | 38041196 | PubTator, text mining | PubMed |
| Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis. | Cancer Cell Int | 2023 | 38041068 | PubTator, text mining | PubMed |
| The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis. | Mol Cancer | 2023 | 38037077 | PubTator, text mining | PubMed |
| Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs. | Front Immunol | 2023 | 38035068 | PubTator, text mining | PubMed |
| Immune microenvironment dynamics of HER2 overexpressing breast cancer under dual anti-HER2 blockade. | Front Immunol | 2023 | 38022643 | PubTator, text mining | PubMed |
| Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy. | Front Immunol | 2023 | 38022518 | PubTator, text mining | PubMed |
| Morphological and functional cardiac alterations in children with congenital Zika syndrome and severe neurological deficits. | PLoS Negl Trop Dis | 2023 | 38019886 | PubTator, text mining | PubMed |
| Identifying individualized prognostic signature and unraveling the molecular mechanism of recurrence in early-onset colorectal cancer. | Eur J Med Res | 2023 | 37986009 | PubTator, text mining | PubMed |
| The molecular landscape of neurological disorders: insights from single-cell RNA sequencing in neurology and neurosurgery. | Eur J Med Res | 2023 | 37974227 | PubTator, text mining | PubMed |
| AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers. | Explor Target Antitumor Ther | 2023 | 37970208 | PubTator, text mining | PubMed |
| The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling. | Breast Cancer Res | 2023 | 37968653 | PubTator, text mining | PubMed |
| Insights into the regulatory role of RNA methylation modifications in glioma. | J Transl Med | 2023 | 37964279 | PubTator, text mining | PubMed |
| The Tolerogenic Influence of Dexamethasone on Dendritic Cells Is Accompanied by the Induction of Efferocytosis, Promoted by MERTK. | Int J Mol Sci | 2023 | 37958886 | PubTator, text mining | PubMed |
| Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities. | Int J Mol Sci | 2023 | 37958483 | PubTator, text mining | PubMed |
| The Role of Macrophages in Sarcoma Tumor Microenvironment and Treatment. | Cancers (Basel) | 2023 | 37958467 | PubTator, text mining | PubMed |
| Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer. | Matrix Biol | 2023 | 37956856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8205/papers?page=13